Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects
Peter Gasser, Katharina Kirchner, Torsten Passie
Journal of Psychopharmacology (2014) Vol. 29, Iss. 1, pp. 57-68
Closed Access | Times Cited: 399

Showing 1-25 of 399 citing articles:

Psychedelics
David E. Nichols
Pharmacological Reviews (2016) Vol. 68, Iss. 2, pp. 264-355
Open Access | Times Cited: 1293
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
Leor Roseman, David Nutt, Robin Carhart‐Harris
Frontiers in Pharmacology (2018) Vol. 8
Open Access | Times Cited: 636
Serotonin and brain function: a tale of two receptors
RL Carhart-Harris, DJ Nutt
Journal of Psychopharmacology (2017) Vol. 31, Iss. 9, pp. 1091-1120
Open Access | Times Cited: 593
Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression
Rosalind Watts, Camilla Day, Jacob Krzanowski, et al.
Journal of Humanistic Psychology (2017) Vol. 57, Iss. 5, pp. 520-564
Closed Access | Times Cited: 444
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Franz X. Vollenweider, Katrin H. Preller
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 11, pp. 611-624
Closed Access | Times Cited: 406
Crystal Structure of an LSD-Bound Human Serotonin Receptor
Daniel Wacker, Sheng Wang, John D. McCorvy, et al.
Cell (2017) Vol. 168, Iss. 3, pp. 377-389.e12
Open Access | Times Cited: 405
Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor
Kuglae Kim, Tao Che, Ouliana Panova, et al.
Cell (2020) Vol. 182, Iss. 6, pp. 1574-1588.e19
Open Access | Times Cited: 373
Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology
Ido Hartogsohn
Journal of Psychopharmacology (2016) Vol. 30, Iss. 12, pp. 1259-1267
Closed Access | Times Cited: 366
Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population
Peter S. Hendricks, Christopher B. Thorne, C. Brendan Clark, et al.
Journal of Psychopharmacology (2015) Vol. 29, Iss. 3, pp. 280-288
Closed Access | Times Cited: 339
Psychedelics as Medicines: An Emerging New Paradigm
DE Nichols, MW Johnson, CD Nichols
Clinical Pharmacology & Therapeutics (2016) Vol. 101, Iss. 2, pp. 209-219
Closed Access | Times Cited: 296
Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
Leor Roseman, Eline Haijen, Kelvin Idialu-Ikato, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 9, pp. 1076-1087
Closed Access | Times Cited: 290
LSD‐induced entropic brain activity predicts subsequent personality change
Alexander V. Lebedev, Mendel Kaelen, Martin Lövdén, et al.
Human Brain Mapping (2016) Vol. 37, Iss. 9, pp. 3203-3213
Open Access | Times Cited: 287
Psychiatry & the psychedelic drugs. Past, present & future
James Rucker, Jonathan Iliff, David Nutt
Neuropharmacology (2017) Vol. 142, pp. 200-218
Open Access | Times Cited: 276
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
Rafael G. dos Santos, Flávia de Lima Osório, José Alexandre S. Crippa, et al.
Therapeutic Advances in Psychopharmacology (2016) Vol. 6, Iss. 3, pp. 193-213
Open Access | Times Cited: 273
Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
Gabrielle Agin-Liebes, Tara C. Malone, Matthew M. Yalch, et al.
Journal of Psychopharmacology (2020) Vol. 34, Iss. 2, pp. 155-166
Closed Access | Times Cited: 260
Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies
Kristoffer A. A. Andersen, Robin Carhart‐Harris, David Nutt, et al.
Acta Psychiatrica Scandinavica (2020) Vol. 143, Iss. 2, pp. 101-118
Closed Access | Times Cited: 253
Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis
Alexander B. Belser, Gabrielle Agin-Liebes, Thomas Cody Swift, et al.
Journal of Humanistic Psychology (2017) Vol. 57, Iss. 4, pp. 354-388
Closed Access | Times Cited: 241
Phenomenology, Structure, and Dynamic of Psychedelic States
Katrin H. Preller, Franz X. Vollenweider
Current topics in behavioral neurosciences (2016), pp. 221-256
Closed Access | Times Cited: 223
Effects of psilocybin therapy on personality structure
David Erritzøe, Leor Roseman, Matthew M. Nour, et al.
Acta Psychiatrica Scandinavica (2018) Vol. 138, Iss. 5, pp. 368-378
Open Access | Times Cited: 223
LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
Patrick C. Dolder, Yasmin Schmid, Felix Müller, et al.
Neuropsychopharmacology (2016) Vol. 41, Iss. 11, pp. 2638-2646
Open Access | Times Cited: 211
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Simone B. Sartori, Nicolas Singewald
Pharmacology & Therapeutics (2019) Vol. 204, pp. 107402-107402
Open Access | Times Cited: 205
Modern Clinical Research on LSD
Matthias E. Liechti
Neuropsychopharmacology (2017) Vol. 42, Iss. 11, pp. 2114-2127
Open Access | Times Cited: 197
Long-lasting subjective effects of LSD in normal subjects
Yasmin Schmid, Matthias E. Liechti
Psychopharmacology (2017) Vol. 235, Iss. 2, pp. 535-545
Open Access | Times Cited: 196
DMT Models the Near-Death Experience
Christopher Timmermann, Leor Roseman, L. Williams, et al.
Frontiers in Psychology (2018) Vol. 9
Open Access | Times Cited: 190
Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development
Eduardo Ekman Schenberg
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 187
Page 1 - Next Page

Scroll to top